# Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke

> **NCT04205526** · NA · UNKNOWN · sponsor: **Thiel, Alexander, M.D.** · enrollment: 49 (estimated)

## Conditions studied

- Feasibility Study

## Interventions

- **DEVICE:** Active rTMS
- **DEVICE:** Sham TMS

## Key facts

- **NCT ID:** NCT04205526
- **Lead sponsor:** Thiel, Alexander, M.D.
- **Sponsor class:** INDIV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-06-30
- **Target enrollment:** 49 (ESTIMATED)
- **Last updated:** 2022-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04205526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04205526, "Contralesional Inhibitory rTMS for Recovery of Arm Function After Stroke". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04205526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*